Clinical Cancer Research

Abkürzung der Fachzeitschrift: CLIN CANCER RES
ISSN: 1078-0432
Verlag: American Association for Cancer Research


Go to first page Go to previous page 1 von 2 Go to next page Go to last page

Heftnummer: 13, Band: 25, Seitenbereich: 3986-3995
Mutational diversity and therapy response in breast cancer: A sequencing analysis in the neoadjuvant geparsepto trial (2019)
Loibl S, Treue D, Budczies J, et al.

Heftnummer: 7, Band: 24, Seitenbereich: 1586-1593
Molecular Markers Increase Precision of the European Association of Urology Non-Muscle-Invasive Bladder Cancer Progression Risk Groups (2018)
Van Kessel KEM, Van Der Keur KA, Dyrskjot L, et al.

Heftnummer: 14, Band: 24, Seitenbereich: 3358-3365
Risk Assessment after Neoadjuvant Chemotherapy in Luminal Breast Cancer Using a Clinicomolecular Predictor (2018)
Loibl S, Weber K, Huober J, et al.

Heftnummer: 22, Band: 22, Seitenbereich: 5487-5496
Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab (2016)
Weide B, Martens A, Hassel JC, et al.

Heftnummer: 17, Band: 22, Seitenbereich: 4356-65
Genomic EWSR1 Fusion Sequence as Highly Sensitive and Dynamic Plasma Tumor Marker in Ewing Sarcoma (2016)
Krumbholz M, Hellberg J, Steif B, et al.

Heftnummer: 11, Band: 22, Seitenbereich: 2675-83
Integrated Analysis of PTEN and p4EBP1 Protein Expression as Predictors for pCR in HER2-Positive Breast Cancer (2016)
Loibl S, Darb-Esfahani S, Huober J, et al.

Heftnummer: 10, Band: 22, Seitenbereich: 2583-93
Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer (2016)
Janni WJ, Rack B, Terstappen LWMM, et al.

Heftnummer: 23, Band: 22, Seitenbereich: 5747-5754
Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast Cancer (2016)
Heppner BI, Untch M, Denkert C, et al.

Zuletzt aktualisiert 2015-29-05 um 16:46